These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11727399)

  • 1. Cardiomyopathy and heart failure in diabetes.
    Tang WH; Young JB
    Endocrinol Metab Clin North Am; 2001 Dec; 30(4):1031-46. PubMed ID: 11727399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicinal chemistry of drugs used in diabetic cardiomyopathy.
    Adeghate E; Kalasz H; Veress G; Teke K
    Curr Med Chem; 2010; 17(6):517-51. PubMed ID: 20015035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Other drug treatments: the evidence.
    Poulter N
    Proc Nutr Soc; 2000 Aug; 59(3):425-6. PubMed ID: 10997663
    [No Abstract]   [Full Text] [Related]  

  • 4. [Glycemic regulation and management of essential hypertension in diabetics with type 2 diabetes mellitus; the 'United Kingdom prospective diabetes study' of diabetic complications].
    Wolffenbuttel BH; Heine RJ
    Ned Tijdschr Geneeskd; 1999 Jun; 143(23):1197-201. PubMed ID: 10389533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of obesity hypertension and diabetes syndrome.
    Zanella MT; Kohlmann O; Ribeiro AB
    Hypertension; 2001 Sep; 38(3 Pt 2):705-8. PubMed ID: 11566961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta blockers and diuretics: therapeutic drugs of first choice in diabetes mellitus and hypertension].
    Sawicki PT
    Wien Klin Wochenschr; 1995; 107(21):629-39. PubMed ID: 8578749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertension in diabetes mellitus].
    Jermendy G
    Orv Hetil; 2009 Sep; 150(39):1813-23. PubMed ID: 19758961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neither diabetes nor glucose-lowering drugs are associated with mortality after noncardiac surgery in patients with coronary artery disease or heart failure.
    Hanninen M; McAlister FA; Bakal JA; van Diepen S; Ezekowitz JA
    Can J Cardiol; 2013 Apr; 29(4):423-8. PubMed ID: 22985785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of the diabetic patient with prior cardiovascular events.
    Fonarow GC
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S38-49. PubMed ID: 14668702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.
    Goa KL; Haria M; Wilde MI
    Drugs; 1997 Jun; 53(6):1081-105. PubMed ID: 9179532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing patterns and therapeutic implications for diabetic hypertension in Bahrain.
    Al Khaja KA; Sequeira RP; Mathur VS
    Ann Pharmacother; 2001 Nov; 35(11):1350-9. PubMed ID: 11724081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials.
    Shekelle PG; Rich MW; Morton SC; Atkinson CS; Tu W; Maglione M; Rhodes S; Barrett M; Fonarow GC; Greenberg B; Heidenreich PA; Knabel T; Konstam MA; Steimle A; Warner Stevenson L
    J Am Coll Cardiol; 2003 May; 41(9):1529-38. PubMed ID: 12742294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials.
    Wang JG; Staessen JA; Li Y; Van Bortel LM; Nawrot T; Fagard R; Messerli FH; Safar M
    Stroke; 2006 Jul; 37(7):1933-40. PubMed ID: 16763185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirements for antihypertensive therapy in diabetic patients: metabolic aspects.
    Teuscher AU; Weidmann PU
    J Hypertens Suppl; 1997 Mar; 15(2):S67-75. PubMed ID: 9218202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care.
    Vijan S; Hayward RA
    Ann Intern Med; 2003 Apr; 138(7):593-602. PubMed ID: 12667032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor adherence with ACE inhibitors is a risk factor of CVA with oral hypoglycemic agents in diabetic patients.
    Aftab MT; Dharamshi HA; Faraz A; Shakeel S; Shakeel O
    Pak J Pharm Sci; 2017 Mar; 30(2):415-419. PubMed ID: 28649065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 diabetes and chronic systolic heart failure: clinical implications.
    Langford MC
    J Cardiovasc Nurs; 2004; 19(6 Suppl):S35-44; quiz S45-6. PubMed ID: 15529072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case for beta-blockers as first-line antihypertensive therapy.
    Cruickshank JM
    J Hypertens Suppl; 1992 Jun; 10(3):S21-7. PubMed ID: 1353111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive treatment of patients with diabetes and hypertension.
    Julius S; Majahalme S; Palatini P
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):310S-316S. PubMed ID: 11721889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update in pharmacologic treatment of hypertension.
    Ferdinand KC
    Cardiol Clin; 2001 May; 19(2):279-94, v. PubMed ID: 11407110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.